The chemotherapeutic Paclitaxel is listed by the World Health Organization as an essential medicine (WHO, 2021) and is one of the most intensively used anti-tumor drugs, yet is notoriously difficult to produce. By producing Paclitaxel in efficiently farmed soybeans, the CU-Boulder team hopes to provide a sustainable and relatively inexpensive method of producing this essential chemotherapeutic. To accomplish this, the CU-Boulder team is introducing enzymes of the Paclitaxel biosynthesis pathway from the Yew tree into soybeans.